An Open-label, Phase 2 Study of ACP-196 (Acalabrutinib) in Subjects With Mantle Cell Lymphoma
Clinical trial NCT02213926 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02213926
- Sponsor
- Acerta Pharma BV
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-02
- Primary completion
- 2020-12-04
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.